Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
136.50
+0.50 (0.37%)
At close: Feb 13, 2026
Market Cap10.74B
Revenue (ttm)496.63M +47.4%
Net Income144.81M
EPS2.15
Shares Out78.71M
PE Ratio63.35
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,800
Average Volume57,650
Open136.20
Previous Close136.00
Day's Range134.50 - 136.70
52-Week Range97.50 - 161.70
Betan/a
RSI46.28
Earnings Daten/a

About HKG:2637

Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. The company was incorporated in 2012 and is based in Fuzhou, China. [Read more]

Industry Pharmaceutical Preparations
Founded 2012
Employees 164
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2637
Full Company Profile

Financial Performance

In 2024, HKG:2637's revenue was 466.68 million, an increase of 47.39% compared to the previous year's 316.63 million. Earnings were 136.08 million, an increase of 15.86%.

Financial numbers in CNY Financial Statements